Who We Are

Donald L. Reynolds, PhD & Associates, Inc. offers a broad range of expertise and services in pharmaceutical drug development, with a primary focus in bioanalytical and pharmaceutical chemistry. 

Dr. Donald L. Reynolds

We have more than 30 years of drug development experience with new products and generics, and we have provided bioanalytical expertise to US and International Pharmaceutical and Biopharmaceutical companies, Contract Research Organizations and Institutional Financial Management Clients.

Our company was founded on the principles of honesty, integrity and respect, and our corporate culture was designed to ensure that others are treated the way they want to be treated.  Our in-depth experience across all stages of drug development (Discovery Support – Post Approval) enables us to offer expert solutions to address your specific bioanalytical needs from both scientific and regulatory perspectives.  In addition, our extensive hands-on experience in both Pharma and CRO environments uniquely qualifies us to expedite development programs for Pharma Clients working with external CROs as well as to enhance expertise, processes and profitability in a contracting environment.  We understand the sense of urgency required for you to achieve your Company goals, and we are committed to providing quality services in a timely manner.  Offered services encompass the Scientific/Technical, Regulatory/Data and Scientific and Business Process areas.

We have partnered with Juliane Carvalho at Brazil Pharma News to provide complete and accurate English translations of selected ANVISA documents published in the Federal Official Gazette of Brazil.  Currently available translation documents are located on the ANVISA Documents and English Translations section, and translation services for other ANVISA documents are available upon request.  Please contact us for additional information.



To facilitate the timely completion of drug development programs for US and International Pharma, Biopharma and CRO clients by evaluating and improving bioanalytical processes, ensuring that bioanalytical methods are appropriately designed and validated, and that quality bioanalytical study data are generated and accurately reported in accordance with current acceptable global Scientific and Regulatory practices